Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
- Posted on June 2, 2026
- By Bing News
- 0 Views
- 1 min read
Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and deadliest cancers for women. Blockbuster weight loss drugs like Ozempic and Wegovy have been linked to numerous benefits beyond weight loss, such as cutting the risk of obesity-related cancers in half. And new research has found that women taking a GLP-1 medication are less likely to develop breast cancer. Accounting for about...
